Evidence supporting the use of: Rutin
For the health condition: Osteoporosis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Rutin, a flavonoid glycoside found in various plants such as buckwheat, citrus fruits, and apples, has been investigated for its potential benefits in bone health, including osteoporosis. Preclinical studies, primarily in animal models and cell cultures, suggest that rutin may exert protective effects against osteoporosis through its antioxidant, anti-inflammatory, and anti-osteoclastogenic properties. Rutin appears to mitigate oxidative stress—a factor implicated in bone loss—by scavenging free radicals and upregulating antioxidant enzymes. Additionally, some studies indicate that rutin can inhibit the differentiation and activity of osteoclasts (cells responsible for bone resorption), while promoting osteoblast function (cells responsible for bone formation). For example, research in ovariectomized rats (a common model for postmenopausal osteoporosis) has demonstrated that rutin supplementation can prevent bone mineral density loss and improve bone microarchitecture.

However, despite promising laboratory and animal data, robust clinical trials in humans are lacking. There is insufficient evidence to recommend rutin as a primary or adjunctive therapy for osteoporosis in clinical practice. The current scientific support is limited to preclinical research, and its translation to human health outcomes remains uncertain. Therefore, while the use of rutin for osteoporosis is scientifically grounded in mechanistic studies, the overall evidence is weak (rated 2/5), and routine clinical use cannot be justified without further research.

More about rutin
More about Osteoporosis